As the Brexit transition period draws to an end, the team at Boyds is keeping close to the latest developments to support clients in their preparedness for the 1st January 2021 and beyond.
Furthermore, our Dublin office provides the foothold in Europe to ensure our clients can continue to benefit from access to the European Medicines Agency.
We aim to bring you the latest updates from the regulatory authorities and post updates on this page. We also produce a monthly Regulatory Affairs Digest and you can follow us on twitter @boydconsultants to keep up to date with the latest guidance and advice.
Get in touch to speak to the member of the team.
Regulatory Affairs Digest
The regulatory team at Boyds regularly reviews all the latest developments from the regulatory authorities during the Brexit transition. Below are links to recent issues of our digest. To sign up and receive these direct to your inbox, complete the sign up form on this page.